FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1814323908> ?p ?o ?g. }

• W1814323908 endingPage "2007" @default.
• W1814323908 startingPage "2002" @default.
• W1814323908 abstract "The aim of this study was to investigate the effects of systemically administered zoledronic acid (ZOL) on the progression of periapical lesions in estrogen-deficient rats.Female Wistar rats were divided into the following groups: SHAM-veh, sham surgery treated with vehicle (physiological saline); OVX-veh, ovariectomy treated with vehicle; SHAM-ZOL, sham surgery treated with ZOL; and OVX-ZOL, ovariectomy treated with ZOL. Vehicle or ZOL was administered intravenously once a week for 4 weeks. The pulp of the mandibular first molar of all rats was exposed to the oral environment to induce a periapical lesion, and the lesions were analyzed after 7 and 30 days. The mandibles were examined by micro-computed tomographic imaging and histopathologic, histometric, and immunohistochemical analyses.Histopathologically, the OVX-veh group had more severe inflammation and bone loss and a larger number of cells that were positive for tartrate-resistant acid phosphatase compared with the SHAM-veh and OVX-ZOL groups; the SHAM-veh and OVX-ZOL groups were similar to each other. The SHAM-ZOL group had the lowest magnitude of these conditions. Tomographically, the OVX-veh group had greater bone loss than the other groups at both time points. The SHAM-veh, SHAM-ZOL, and OVX-ZOL groups had similar bone loss at both time points. In the sagittal section on day 30, the SHAM-ZOL group had lower bone loss compared with the SHAM-veh and OVX-ZOL groups.The hypoestrogenic condition aggravates the progression of periapical lesions. ZOL therapy may help contain bone destruction of periapical lesions." @default.
• W1814323908 created "2016-06-24" @default.
• W1814323908 creator A5015454477 @default.
• W1814323908 creator A5027250001 @default.
• W1814323908 creator A5027543661 @default.
• W1814323908 creator A5042266010 @default.
• W1814323908 creator A5053145977 @default.
• W1814323908 creator A5069774952 @default.
• W1814323908 creator A5072879091 @default.
• W1814323908 creator A5081846981 @default.
• W1814323908 creator A5084616637 @default.
• W1814323908 date "2015-12-01" @default.
• W1814323908 modified "2023-10-14" @default.
• W1814323908 title "Diminished Progression of Periapical Lesions with Zoledronic Acid in Ovariectomized Rats" @default.
• W1814323908 cites W1522188301 @default.
• W1814323908 cites W1536865010 @default.
• W1814323908 cites W1881952764 @default.
• W1814323908 cites W1918195936 @default.
• W1814323908 cites W1968451395 @default.
• W1814323908 cites W1974470716 @default.
• W1814323908 cites W1990198216 @default.
• W1814323908 cites W1999472804 @default.
• W1814323908 cites W2015902352 @default.
• W1814323908 cites W2017842664 @default.
• W1814323908 cites W2018330838 @default.
• W1814323908 cites W2021035060 @default.
• W1814323908 cites W2034306878 @default.
• W1814323908 cites W2046049255 @default.
• W1814323908 cites W2049130176 @default.
• W1814323908 cites W2049178414 @default.
• W1814323908 cites W2061216954 @default.
• W1814323908 cites W2075463681 @default.
• W1814323908 cites W2075756678 @default.
• W1814323908 cites W2078858963 @default.
• W1814323908 cites W2084217437 @default.
• W1814323908 cites W2087440966 @default.
• W1814323908 cites W2093354768 @default.
• W1814323908 cites W2094762468 @default.
• W1814323908 cites W2116095052 @default.
• W1814323908 cites W2118091075 @default.
• W1814323908 cites W2125127320 @default.
• W1814323908 cites W2143903051 @default.
• W1814323908 doi "https://doi.org/10.1016/j.joen.2015.08.029" @default.
• W1814323908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26490005" @default.
• W1814323908 hasPublicationYear "2015" @default.
• W1814323908 type Work @default.
• W1814323908 sameAs 1814323908 @default.
• W1814323908 citedByCount "20" @default.
• W1814323908 countsByYear W18143239082016 @default.
• W1814323908 countsByYear W18143239082017 @default.
• W1814323908 countsByYear W18143239082018 @default.
• W1814323908 countsByYear W18143239082019 @default.
• W1814323908 countsByYear W18143239082020 @default.
• W1814323908 countsByYear W18143239082021 @default.
• W1814323908 countsByYear W18143239082022 @default.
• W1814323908 countsByYear W18143239082023 @default.
• W1814323908 crossrefType "journal-article" @default.
• W1814323908 hasAuthorship W1814323908A5015454477 @default.
• W1814323908 hasAuthorship W1814323908A5027250001 @default.
• W1814323908 hasAuthorship W1814323908A5027543661 @default.
• W1814323908 hasAuthorship W1814323908A5042266010 @default.
• W1814323908 hasAuthorship W1814323908A5053145977 @default.
• W1814323908 hasAuthorship W1814323908A5069774952 @default.
• W1814323908 hasAuthorship W1814323908A5072879091 @default.
• W1814323908 hasAuthorship W1814323908A5081846981 @default.
• W1814323908 hasAuthorship W1814323908A5084616637 @default.
• W1814323908 hasBestOaLocation W18143239082 @default.
• W1814323908 hasConcept C126322002 @default.
• W1814323908 hasConcept C126894567 @default.
• W1814323908 hasConcept C134018914 @default.
• W1814323908 hasConcept C142724271 @default.
• W1814323908 hasConcept C181199279 @default.
• W1814323908 hasConcept C185592680 @default.
• W1814323908 hasConcept C199343813 @default.
• W1814323908 hasConcept C204787440 @default.
• W1814323908 hasConcept C21547065 @default.
• W1814323908 hasConcept C2775961468 @default.
• W1814323908 hasConcept C2776326535 @default.
• W1814323908 hasConcept C2777164284 @default.
• W1814323908 hasConcept C2777397205 @default.
• W1814323908 hasConcept C2781156865 @default.
• W1814323908 hasConcept C55493867 @default.
• W1814323908 hasConcept C71924100 @default.
• W1814323908 hasConcept C8264082 @default.
• W1814323908 hasConceptScore W1814323908C126322002 @default.
• W1814323908 hasConceptScore W1814323908C126894567 @default.
• W1814323908 hasConceptScore W1814323908C134018914 @default.
• W1814323908 hasConceptScore W1814323908C142724271 @default.
• W1814323908 hasConceptScore W1814323908C181199279 @default.
• W1814323908 hasConceptScore W1814323908C185592680 @default.
• W1814323908 hasConceptScore W1814323908C199343813 @default.
• W1814323908 hasConceptScore W1814323908C204787440 @default.
• W1814323908 hasConceptScore W1814323908C21547065 @default.
• W1814323908 hasConceptScore W1814323908C2775961468 @default.
• W1814323908 hasConceptScore W1814323908C2776326535 @default.
• W1814323908 hasConceptScore W1814323908C2777164284 @default.
• W1814323908 hasConceptScore W1814323908C2777397205 @default.
• W1814323908 hasConceptScore W1814323908C2781156865 @default.

• next